Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis

BACKGROUND AND AIMS: Treatment of de novo malignancies and recurrent hepatocellular carcinoma with immune checkpoint inhibitors (ICI) in liver transplant recipients (LT) is an attractive strategy that is infrequently pursued because of the lack of strong evidence regarding their safety and efficacy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kayali, Stefano, Pasta, Andrea, Plaz Torres, Maria Corina, Jaffe, Ariel, Strazzabosco, Mario, Marenco, Simona, Giannini, Edoardo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews & Meta‐analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087158/
https://www.ncbi.nlm.nih.gov/pubmed/36102312
http://dx.doi.org/10.1111/liv.15419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087158/
https://www.ncbi.nlm.nih.gov/pubmed/36102312
http://dx.doi.org/10.1111/liv.15419

Ejemplares similares